Skip to main content
Erschienen in: Supportive Care in Cancer 10/2020

11.07.2020 | Review Article

Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review

verfasst von: Christopher J. Longo, Margaret I. Fitch, Laura Banfield, Paul Hanly, K. Robin Yabroff, Linda Sharp

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Financial toxicity related to cancer diagnosis and treatment is a common issue in developed countries. We seek to systematically summarize the extent of the issue in very high development index countries with publicly funded healthcare.

Methods

We identified articles published Jan 1, 2005, to March 7, 2019, describing financial burden/toxicity experienced by cancer patients and/or informal caregivers using OVID Medline Embase and PsychInfo, CINAHL, Business Source Complete, and EconLit databases. Only English language peer-reviewed full papers describing studies conducted in very high development index countries with predominantly publicly funded healthcare were eligible (excluded the USA). All stages of the review were evaluated in teams of two researchers excepting the final data extraction (CJL only).

Results

The searches identified 7117 unique articles, 32 of which were eligible. Studies were undertaken in Canada, Australia, Ireland, UK, Germany, Denmark, Malaysia, Finland, France, South Korea, and the Netherlands. Eighteen studies reported patient/caregiver out-of-pocket costs (range US$17–US$506/month), 18 studies reported patient/caregiver lost income (range 17.6–67.3%), 14 studies reported patient/caregiver travel and accommodation costs (range US$8–US$393/month), and 6 studies reported financial stress (range 41–48%), strain (range 7–39%), or financial burden/distress/toxicity among patients/caregivers (range 22–27%). The majority of studies focused on patients, with some including caregivers. Financial toxicity was greater in those with early disease and/or more severe cancers.

Conclusions

Despite government-funded universal public healthcare, financial toxicity is an issue for cancer patients and their families. Although levels of toxicity vary between countries, the findings suggest financial protection appears to be inadequate in many countries.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Zafar SY, Abernethy AP (2013) Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park) 27:80–149 Zafar SY, Abernethy AP (2013) Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park) 27:80–149
16.
Zurück zum Zitat Kmet L M, Lee R C, Cook L S (2004) Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Edmonton: Alberta Heritage Foundation for Medical Research (AHFMR). AHFMR - HTA Initiative #13. Kmet L M, Lee R C, Cook L S (2004) Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Edmonton: Alberta Heritage Foundation for Medical Research (AHFMR). AHFMR - HTA Initiative #13.
17.
Zurück zum Zitat Butler L, Downe-Wamboldt B, Melanson P, Coulter L, Keefe J, Singleton J, Bell D (2006) Prevalence, correlates, and costs of patients with poor adjustment to mixed cancers. Cancer Nurs 29:9–16CrossRefPubMed Butler L, Downe-Wamboldt B, Melanson P, Coulter L, Keefe J, Singleton J, Bell D (2006) Prevalence, correlates, and costs of patients with poor adjustment to mixed cancers. Cancer Nurs 29:9–16CrossRefPubMed
18.
Zurück zum Zitat Longo CJ, Fitch M, Deber RB, Williams AP (2006) Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer 14:1077–1085CrossRefPubMed Longo CJ, Fitch M, Deber RB, Williams AP (2006) Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer 14:1077–1085CrossRefPubMed
19.
Zurück zum Zitat Longo CJ, Deber R, Fitch M et al (2007) An examination of cancer patients’ monthly “out-of-pocket” costs in Ontario, Canada. J Cancer Care 16:500–507CrossRef Longo CJ, Deber R, Fitch M et al (2007) An examination of cancer patients’ monthly “out-of-pocket” costs in Ontario, Canada. J Cancer Care 16:500–507CrossRef
20.
Zurück zum Zitat Longo CJ, Bereza BG (2011) A comparative analysis of monthly out-of-pocket costs for patients with breast cancer as compared with other common cancers in Ontario, Canada. Curr Oncol 18:e1–e8CrossRefPubMedPubMedCentral Longo CJ, Bereza BG (2011) A comparative analysis of monthly out-of-pocket costs for patients with breast cancer as compared with other common cancers in Ontario, Canada. Curr Oncol 18:e1–e8CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Balneaves LG, Bottorff JL, Hislop TG, Herbert C (2006) Levels of commitment: exploring complementary therapy use by women with breast cancer. J Altern 12:459–466 Balneaves LG, Bottorff JL, Hislop TG, Herbert C (2006) Levels of commitment: exploring complementary therapy use by women with breast cancer. J Altern 12:459–466
22.
Zurück zum Zitat Gordon L, Scuffham P, Hayes S, Newman B (2007) Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psycho-Oncology 16:1130–1139CrossRefPubMed Gordon L, Scuffham P, Hayes S, Newman B (2007) Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psycho-Oncology 16:1130–1139CrossRefPubMed
23.
Zurück zum Zitat Gordon LG, Ferguson M, Chambers SK, Dunn J (2009) Fuel, beds, meals and meds: out-of-pocket expenses for patients with cancer in rural Queensland. Cancer Forum 33:202–208 Gordon LG, Ferguson M, Chambers SK, Dunn J (2009) Fuel, beds, meals and meds: out-of-pocket expenses for patients with cancer in rural Queensland. Cancer Forum 33:202–208
31.
45.
Zurück zum Zitat Arndt V, Koch-Gallenkamp L, Bertram H, et al (2019) Return to work after cancer. A multi-regional population-based study from Germany Arndt V, Koch-Gallenkamp L, Bertram H, et al (2019) Return to work after cancer. A multi-regional population-based study from Germany
Metadaten
Titel
Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: a systematic review
verfasst von
Christopher J. Longo
Margaret I. Fitch
Laura Banfield
Paul Hanly
K. Robin Yabroff
Linda Sharp
Publikationsdatum
11.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05620-9

Weitere Artikel der Ausgabe 10/2020

Supportive Care in Cancer 10/2020 Zur Ausgabe

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.